𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimal Iron Management in Patients Receiving Erythropoietin Therapy

✍ Scribed by Iain C. Macdougall

Book ID
109082318
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
539 KB
Volume
11
Category
Article
ISSN
0894-0959

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of iron treatment on circulating
Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin
✍ Weiss, Günter; Meusburger, Edgar; Radacher, Gudrun; Garimorth, Katja; Neyer, Ul πŸ“‚ Article πŸ“… 2003 πŸ› Nature Publishing Group 🌐 English βš– 146 KB

## Background: Anemia in patients with end-stage renal disease (esrd) is treated with recombinant human erythropoietin (rhepo) often in combination with iron. however, iron catalyzes the formation of toxic radicals, which might promote vascular damage, is a nutrient for microorganisms, and negative

Concurrent electroconvulsive therapy in
Concurrent electroconvulsive therapy in patients receiving reboxetine
✍ Ashok N. Singh πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 53 KB

There are few studies of the potential interaction between antidepressants and electroconvulsive therapy (ECT), although there is a theoretical risk of serotonin syndrome when ECT is used in patients receiving selective serotonin reuptake inhibitors. There may also be an increased cardiovascular ris